Compare FLGT & HPI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | FLGT | HPI |
|---|---|---|
| Founded | 2011 | N/A |
| Country | United States | United States |
| Employees | 1315 | N/A |
| Industry | Medical Specialities | Trusts Except Educational Religious and Charitable |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 537.6M | 435.6M |
| IPO Year | 2016 | 2002 |
| Metric | FLGT | HPI |
|---|---|---|
| Price | $18.80 | $15.95 |
| Analyst Decision | Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $28.33 | N/A |
| AVG Volume (30 Days) | ★ 442.4K | 47.9K |
| Earning Date | 05-01-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $18,730,000.00 | N/A |
| Revenue This Year | $10.09 | N/A |
| Revenue Next Year | $12.18 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $13.46 | $15.26 |
| 52 Week High | $31.04 | $17.61 |
| Indicator | FLGT | HPI |
|---|---|---|
| Relative Strength Index (RSI) | 61.55 | 42.97 |
| Support Level | $13.91 | $15.79 |
| Resistance Level | $19.93 | $16.38 |
| Average True Range (ATR) | 0.85 | 0.18 |
| MACD | 0.06 | -0.02 |
| Stochastic Oscillator | 65.30 | 20.10 |
Fulgent Genetics Inc is a technology company that focuses on genetic testing to provide physicians with clinically actionable diagnostic information. The company is engaged in the laboratory services business and the therapeutic development business. The laboratory services business, which generates key revenue, includes technical laboratory services and professional interpretation of laboratory results by licensed physicians. Its therapeutic development business is focused on developing drug candidates for treating a broad range of cancers. The geographical segments are the United States, which generates the vast majority of the revenue, and Foreign.
John Hancock Preferred Income Fund is a closed-end, diversified management investment company. Its primary investment objective is to provide a high-level of current income consistent with preservation of capital. The fund's secondary investment objective is to provide growth of capital to the extent consistent with its primary investment objective. It seeks to achieve its investment objectives by investing in securities that may be undervalued relative to similar securities in the marketplace. The fund's principal investment strategies include investing a majority of its assets in preferred stocks and other preferred securities. Its portfolio composition consists of U.S preferred securities, common stocks, foreign preferred securities, corporate bonds, and short-term investments.